Introduction
Exogenous carbon monoxide (CO) has long been considered toxic due to competitive 39 inhibition of haemoglobin oxygen binding. However, endogenous CO is increasingly being associated 40 with beneficial physiological effects [1] . Heme is oxidised to produce CO, free iron and biliverdin, a 41 reaction catalysed by heme oxygenase (HO). Of the three known isoforms of HO, HO-1 is highly 42 induced by oxidative stress, it acts to limit damage from the oxidant heme [2] . CO therefore may be 43 a biomarker of oxidative stress. Carbon monoxide can activate soluble guanylate cyclase, and hence 44 the cyclic guanylate monophosphate (cGMP) signalling pathway. This is thought to be a common 45 signalling pathway for CO's anti-apoptotic, anti-inflammatory and vaso-active properties [3, 4] .
46
Protective effects of CO have been demonstrated in laboratory models of sepsis, acute lung injury, 47 organ transplantation and reperfusion injury [5] [6] [7] [8] . In vivo, CO is mostly eliminated in exhaled air, but 48 a proportion remains bound to haemoglobin -this is determined by the rate of CO production and 49 minute ventilation [9] .
50 Elevated levels of exhaled CO are associated with smoking, and patients with chronic 51 respiratory disease [10] . This suggests that exhaled CO may be a marker of lung injury. Elevated 52 exhaled CO levels have also been described in critically ill adults in the intensive care unit (ICU) [11] .
53
However, exhaled CO levels were correlated with arterial carboxyhaemoglobin (COHb) and serum 54 bilirubin levels, suggesting increased CO production due to increased in systemic HO activity rather 55 than lung injury in critical illness [12] .
56
Arterial COHb levels have previously been associated with outcomes in adult ICU patients. Figure 3 ). COHb values were slightly better at predicting survival status at PICU discharge. 
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224
Our data also demonstrated that COHb increases with time. It is therefore unsurprising that 225 the maximum COHb correlates with length of ventilation and mortality: the maximum value is 226 likeliest to occur prior to death. In our cohort this is confounded by the use of arterial samples only: Our study has several limitations. Our numbers are restricted by only including children with 250 arterial samples, although these are children are likely to have more severe disease, and have a 251 higher risk of mortality (U.K. baseline PICU mortality 3.8% cf 8.6% in our cohort). We excluded 252 children who required CVVH given the risk of extra-corporeal haemolysis. However these children 253 are likely to have greater severity of illness needing organ support, and data from them may still be 254 of value. Our cohort did not include children post cardio-pulmonary bypass or on extracorporeal life 255 support -this population need consideration, but are likely to have different COHb profiles and 256 associations (similar to differences between the corresponding Fazekas and Melley cohorts). We did 257 not consider haemoglobin levels, which had been shown to be associated with COHb levels in premature neonates [16] . However, haemoglobin levels are likely to be more variable in the early 259 neonatal period, with greater haemolysis.
260
While CO has a potential protective effect through reducing reactive species mediated 261 inflammation; we did not see evidence of this in our population. Further work may be needed to 
